These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2351925

  • 1. The effect of serum lipid regulation on the development of femoral atherosclerosis in hyperlipidaemia: a non-randomized controlled study.
    Olsson AG, Ruhn G, Erikson U.
    J Intern Med; 1990 Jun; 227(6):381-90. PubMed ID: 2351925
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients.
    Barndt R, Blankenhorn DH, Crawford DW, Brooks SH.
    Ann Intern Med; 1977 Feb; 86(2):139-46. PubMed ID: 189658
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Repeat femoral arteriography in hyperlipidemic patients. A study of progression and regression of atherosclerosis.
    Erikson U, Helmius G, Hemmingsson A, Ruhn G, Olsson AG.
    Acta Radiol; 1988 Feb; 29(3):303-9. PubMed ID: 2968099
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
    Vega GL, Ma PT, Cater NB, Filipchuk N, Meguro S, Garcia-Garcia AB, Grundy SM.
    Am J Cardiol; 2003 Apr 15; 91(8):956-60. PubMed ID: 12686335
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidaemia.
    Olsson AG, Carlson LA, Erikson U, Hemius G, Hemmingsson A, Ruhn G.
    Lancet; 1982 Jun 05; 1(8284):1311. PubMed ID: 6123054
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Femoral and coronary atherosclerosis in patients with hyperlipidaemia. Arteriographic findings correlated to clinical and biochemical parameters.
    Bergstrand L.
    Acta Radiol Suppl; 1994 Jun 05; 392():1-27. PubMed ID: 8184697
    [Abstract] [Full Text] [Related]

  • 15. Lipid risk factors in patients requiring arterial reconstruction.
    Seeger JM, Silverman SH, Flynn TC, Bailey JC, Klingman NV, Lawson GA, Borgeson MD, Barratt EJ.
    J Vasc Surg; 1989 Oct 05; 10(4):418-24. PubMed ID: 2795767
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anthocyanins increase low-density lipoprotein and plasma cholesterol and do not reduce atherosclerosis in Watanabe Heritable Hyperlipidemic rabbits.
    Finné Nielsen IL, Elbøl Rasmussen S, Mortensen A, Ravn-Haren G, Ma HP, Knuthsen P, Hansen BF, McPhail D, Freese R, Breinholt V, Frandsen H, Dragsted LO.
    Mol Nutr Food Res; 2005 Apr 05; 49(4):301-8. PubMed ID: 15759306
    [Abstract] [Full Text] [Related]

  • 18. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ, Guérin M, Bruckert E.
    Eur Heart J; 1998 Feb 05; 19 Suppl A():A24-30. PubMed ID: 9519339
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.